GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease
Open Access
- 5 September 2016
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 213 (10), 1983-1998
- https://doi.org/10.1084/jem.20151853
Abstract
Kawasaki disease (KD) is the leading cause of pediatric heart disease in developed countries. KD patients develop cardiac inflammation, characterized by an early infiltrate of neutrophils and monocytes that precipitates coronary arteritis. Although the early inflammatory processes are linked to cardiac pathology, the factors that regulate cardiac inflammation and immune cell recruitment to the heart remain obscure. In this study, using a mouse model of KD (induced by a cell wall Candida albicans water-soluble fraction [CAWS]), we identify an essential role for granulocyte/macrophage colony-stimulating factor (GM-CSF) in orchestrating these events. GM-CSF is rapidly produced by cardiac fibroblasts after CAWS challenge, precipitating cardiac inflammation. Mechanistically, GM-CSF acts upon the local macrophage compartment, driving the expression of inflammatory cytokines and chemokines, whereas therapeutically, GM-CSF blockade markedly reduces cardiac disease. Our findings describe a novel role for GM-CSF as an essential initiating cytokine in cardiac inflammation and implicate GM-CSF as a potential target for therapeutic intervention in KD.Funding Information
- National Health and Medical Research Council (1023407, 0123462)
- National Heart Foundation
- of Australia (1009427)
- John T. Reid Charitable Trusts
This publication has 54 references indexed in Scilit:
- The Dectin-2 family of C-type lectin-like receptors: an updateInternational Immunology, 2013
- Histopathological characteristics of myocarditis in acute‐phase Kawasaki diseaseHistopathology, 2012
- The Chemokine Superfamily RevisitedImmunity, 2012
- Interleukin-1 Is Crucial for the Induction of Coronary Artery Inflammation in a Mouse Model of Kawasaki DiseaseCirculation, 2012
- A genome-wide association study identifies three new risk loci for Kawasaki diseaseNature Genetics, 2012
- Pathogenesis of Kawasaki diseaseClinical and Experimental Immunology, 2011
- GM-CSF mediates autoimmunity by enhancing IL-6–dependent Th17 cell development and survivalThe Journal of Experimental Medicine, 2008
- The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinasesArchives of Disease in Childhood, 2006
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinThe New England Journal of Medicine, 1986
- Enhanced neutrophilic functions in mucocutaneous lymph node syndrome, with special reference to the possible role of increased oxygen intermediate generation in the pathogenesis of coronary thromboarteritisThe Journal of Pediatrics, 1984